<p><P>Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics. </P><P><BR>Ovarian carcinogenes
Ovarian Cancer: Second Edition
โ Scribed by Anna Hoekstra, Gustavo C. Rodriguez (auth.), M. Sharon Stack, David A. Fishman (eds.)
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Leaves
- 408
- Series
- Cancer Treatment and Research 149
- Edition
- 2
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics.
Ovarian carcinogenesis, invasion, and metastatic dissemination require a complex cascade of interrelated genetic, molecular, and biochemical events that regulate the neoplastic transition of normal ovarian surface epithelium.
This second edition includes exciting new advances in ovarian cancer detection and treatment and provides an analysis of current research into aspects of malignant transformation, growth control, and metastasis. A more detailed understanding of these processes may ultimately translate into the development of novel approaches for the detection and control of ovarian cancer.
"Ovarian Cancer prevention, detection and treatment remain a significant health care challenge. In this text thought leaders in the field address the critical biologic and clinical issues relevant to the disease. A comprehensive spectrum of topics is covered providing up to date information on scientific discoveries and management considerations."
Steven T. Rosen, M.D.
โฆ Table of Contents
Front Matter....Pages i-xv
Front Matter....Pages 1-1
Chemoprevention of Ovarian Cancer....Pages 3-34
Staging and Surgical Treatment....Pages 35-61
Novel Therapeutic Targets....Pages 63-84
Biomarker Targets and Novel Therapeutics....Pages 85-105
Front Matter....Pages 107-107
Tumor Suppressor Genes....Pages 109-129
Epigenetics and Ovarian Cancer....Pages 131-146
Aberrant Epithelial Differentiation in Ovarian Cancer....Pages 147-163
The Human Kallikrein Gene Family: New Biomarkers for Ovarian Cancer....Pages 165-187
Soluble Epidermal Growth Factor Receptor: A Biomarker of Epithelial Ovarian Cancer....Pages 189-202
Activated Epidermal Growth Factor Receptor in Ovarian Cancer....Pages 203-226
Front Matter....Pages 227-227
Ras-Superfamily GTP-ases in Ovarian Cancer....Pages 229-240
Lipid Generation and Signaling in Ovarian Cancer....Pages 241-267
Lysophosphatidic Acid and Invasion....Pages 269-296
Cell Adhesion in Ovarian Cancer....Pages 297-318
Microenvironmental Regulation of Ovarian Cancer Metastasis....Pages 319-334
Organotypic Models of Metastasis: A Three-dimensional Culture Mimicking the Human Peritoneum and Omentum for the Study of the Early Steps of Ovarian Cancer Metastasis....Pages 335-351
Animal Models of Ovarian Cancer....Pages 353-391
Back Matter....Pages 393-408
โฆ Subjects
Oncology; Gynecology; Cancer Research; Human Genetics
๐ SIMILAR VOLUMES
<p><P>Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics. </P><P><BR>Ovarian carcinogenes
<P>This comprehensive surgical text, has been updated and expanded and includes the important techniques essential for the effective management of ovarian cancer, with particular emphasis on providing a practical step-by-step approach to the techniques described.</P> <P>This new edition now includes
This official text of the International Association for the Study of Lung Cancer provides a comprehensive and multidisciplinary overview of lung cancer, with contributions from international experts. This new edition has increased coverage of techniques in surgical intervention and therapeutic radia
Advances in research and the treatment of cancer mean that more patients and their carers are asking healthcare professionals about the latest treatments and how they may be of benefit. It is essential that staff working with cancer patients understand fully how these new treatments work in order to